Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gynecological Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT02906943
What this trial is testing

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation

Who this might be right for
Breast CancerLung CancerColorectal Cancer+8 more
University Health Network, Toronto 10,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07769229
What this trial is testing

BL-M09D1 in Patients With Locally Advanced or Metastatic Gynecological Malignancies and Other Solid Tumors

Who this might be right for
Gynecological MalignanciesSolid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 126
Testing effectiveness (Phase 2)Study completedNCT01079832
What this trial is testing

Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies

Who this might be right for
Fallopian Tube CancerOvarian SarcomaOvarian Stromal Cancer+23 more
Case Comprehensive Cancer Center 50
Large-scale testing (Phase 3)Ended earlyNCT00332280
What this trial is testing

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Who this might be right for
Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
Auron Healthcare GmbH 67
Early research (Phase 1)Study completedNCT01065662
What this trial is testing

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

Who this might be right for
Endometrial CancerOvarian CancerCervical Cancer+2 more
Susana M. Campos, MD 11
Not applicableLooking for participantsNCT04957511
What this trial is testing

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

Who this might be right for
Gynecologic CancerImmunotherapyGut Microbiome
Viome 30
Testing effectiveness (Phase 2)Looking for participantsNCT06798207
What this trial is testing

A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

Who this might be right for
Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 170
Early research (Phase 1)Active Not RecruitingNCT05462717
What this trial is testing

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma+1 more
Revolution Medicines, Inc. 222
Very early researchEnded earlyNCT06834542
What this trial is testing

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Who this might be right for
Adult Gynecological Tumors
Grit Biotechnology 1
Not applicableEnded earlyNCT03993210
What this trial is testing

The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids

Who this might be right for
Gynecologic Tumor
Dana-Farber Cancer Institute 1
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Early research (Phase 1)Looking for participantsNCT06977126
What this trial is testing

Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers

Who this might be right for
Gynecological Cancers
University Health Network, Toronto 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076
What this trial is testing

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

Who this might be right for
Endometrial CarcinomaCervix Carcinoma
NETRIS Pharma 240
Testing effectiveness (Phase 2)Study completedNCT04870177
What this trial is testing

Study of AK112 in the Treatment of Advanced Gynecological Tumors

Who this might be right for
Gynecologic CancerCancer MetastaticOvarian Neoplasms+2 more
Akeso 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07738757
What this trial is testing

SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies

Who this might be right for
Recurrent or Metastatic MSI-H/dMMR Gynecological Malignancies
Peking Union Medical College Hospital 80
Not applicableNot Yet RecruitingNCT07490106
What this trial is testing

Benefits of Early Collaboration Between Oncologists and Palliative Care Physicians in Cases of Unplanned Hospitalization for Patients With Metastatic Cancer

Who this might be right for
CancerSarcoma MetastaticGynaecologic Cancer+3 more
Centre Oscar Lambret 493
Testing effectiveness (Phase 2)Looking for participantsNCT06654440
What this trial is testing

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

Who this might be right for
Advanced Gynecological Malignancy
Shanghai Hengrui Pharmaceutical Co., Ltd. 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05152797
What this trial is testing

Efficacy and Safety of TILs in Treatment of Patients With Advanced or Metastatic Refractory Gynecological Cancer

Who this might be right for
Tumor Infiltrating Lymphocytes
Women's Hospital School Of Medicine Zhejiang University 91
Not applicableWithdrawnNCT06145802
What this trial is testing

Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)

Who this might be right for
Solid TumorGynecological Tumors
Grit Biotechnology
Testing effectiveness (Phase 2)Looking for participantsNCT06796907
What this trial is testing

Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

Who this might be right for
Tumours, Gynecological
GlaxoSmithKline 305
Next Page